Pegunigalsidase alfa for Fabry Disease User Reviews
Brand names: Elfabrio
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about pegunigalsidase alfa
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Elfabrio (pegunigalsidase alfa) "This drug seems to give me overall better adverse effects experience than other ERTs I have tried in the past. I also generally feel a lot better day to day on this drug too than the other I tried. Hoping for once-a-month dosing to be approved soon with its longer half-life as well, would be huge for me."